Osteora
Osteora
Select internal fixation solutions engineered for the anatomical specifications and surgical methodologies preferred in French medical centers.
Cardiothoracic surgery practices in France, coordinated through leading Centres Hospitaliers Universitaires (CHUs) and private clinics, are witnessing a structural shift. Traditional wire cerclage, while historically standard, is increasingly replaced by rigid sternal fixation systems for patients with elevated risk factors. Obesity (BMI > 30), Chronic Obstructive Pulmonary Disease (COPD), advanced age, diabetes, and osteoporosis significantly increase the risk of sternal dehiscence and mediastinitis, which carry a mortality rate of up to 40% in French intensive care settings.
The Haute Autorité de Santé (HAS) highlights that securing rigid primary closure reduces micro-motion at the osteotomy margins, accelerating bone healing and lowering surgical site infections (SSI). Consequently, procurement groups like UniHA and Resah prioritize manufacturers offering robust, biocompatible titanium alloy and PEEK implants that meet the stringent safety thresholds of the European Medical Device Regulation (EU MDR 2017/745).
Surgical implants must comply with French LPP (Liste des Produits et Prestations) registration requirements to ensure full reimbursement under the French Social Security system (l'Assurance Maladie). This integration mandates rigorous clinical validation and traceability metrics.
Osteora's anatomical sternal plates deliver balanced force distribution across the sternum. This structural stability minimizes shearing forces during coughing or physical repositioning, facilitating immediate post-operative mobilization.
Osteora Medical Devices Co., Ltd. is a professional orthopedic implant and surgical solution manufacturer specializing in trauma, spine, and joint reconstruction systems under the brand Osteora.
Founded in 2016, the company has developed a strong reputation in the global orthopedic industry through continuous innovation and strict quality control standards. The facility covers an area of approximately 18,500㎡, supporting integrated production, assembly, and testing operations.
With 8 years of export experience and 12 years of industry expertise, Osteora has established stable cooperation with international distributors and hospitals across multiple regions. Annual export revenue ranges from USD 6 million to 14 million, reflecting steady global market growth.
With strong R&D capabilities, Osteora operates an in-house engineering team of 85 R&D engineers, focusing on innovation in trauma fixation systems, spinal implants, and joint reconstruction technologies. The company offers extensive customization options, including OEM/ODM services, size variations, material customization, and private labeling to fit custom clinical requirements within the French health services.
Our production workflow connects with approximately 1,200 certified upstream and downstream partners, guaranteeing supply chain resilience and timely deliveries to European distributors. In the past year, Osteora launched approximately 120 new products, reinforcing our dedication to evolving surgical requirements.
Under the supervision of our 42 specialized quality inspectors, every titanium sternum plate and rib locking implant undergoes a validated validation cycle.
Our quality assurance system integrates ISO 13485 compliance, in-process inspection, and final random sampling testing. Product inspection methods include dimensional measurement, mechanical fatigue testing, and biocompatibility validation, ensuring our devices perform reliably under physiological stresses.
Anatomical variants and patient physiology demand tailored hardware. Rigid sternal fixation comprises three main clinical categories:
Our 85-engineer R&D team optimizes product design to withstand cyclic physiological breathing stresses, reducing the risk of screw backing or plate fatigue.
Each batch of Osteora sternal plates undergoes intensive simulated biomechanical evaluation. Using our Multifunctional Mechanical Testing Machine, components must withstand 5 million cycles of dynamic loading under physiological respiration conditions without structural fatigue or plastic deformation. This standard is critical for compliance within Western European clinical procurement groups.
Our regulatory team manages technical documentation, including Clinical Evaluation Reports (CER) and Post-Market Clinical Follow-up (PMCF) registries, helping distributors navigate ANSM (Agence nationale de sécurité du médicament et des produits de santé) audits.
We work with 1,200 downstream and upstream partners to maintain lead times. Standard items ship with sterile packaging, while custom implants are coordinated directly with surgical planning teams.
Importing medical implants into the French territory requires strict adherence to European regulations. The transition from MDD to MDR demands detailed biocompatibility profiles, packaging integrity assurance, and risk assessments.
Osteora ensures that all surgical instructions (IFUs), labeling, surgical planning software interfaces, and technical datasheets are supplied in French. This supports patient safety and regulatory compliance during clinical audits across CHU networks in Lyon, Marseille, Lille, and Paris.
Working toward the future of personalized cardiothoracic care through research and development.
Developing radio-translucent PEEK composite plates that minimize imaging artifacts on post-operative CT scans, allowing clear assessment of bone healing and mediastinal tissue health.
Employing patient-specific modeling (PSI) based on preoperative high-resolution CT scans to produce custom-molded sternal reconstructive cages for oncology resection cases.
Collaborating with European research laboratories to evaluate dynamic bio-resorbable magnesium-alloy polymers, designed to eliminate the need for hardware removal in pediatric populations.
A comprehensive catalog of CE-certified implants and specialized instrumentation for French orthopedic and trauma surgical centers.
Frequently asked questions concerning compliance, material choice, and procurement dynamics for the French surgical market.
Connect with our engineering and regulatory affairs team for OEM/ODM capabilities, EU MDR certificates, or catalog pricing.
Send Inquiry Now